Biotinylated Human IL-4, Avitag,His Tag (Cat. No. IL4-H82E0) stimulates the proliferation of TF-1 human erythroleukemic cells. The ED50 for this effect is 1.19-2.64 ng/mL (Routinely tested).
Human IL-4, premium grade (Cat. No. IL4-H4218) situmulates proliferation of TF-1 cells. The specific activity of Human IL-4, premium grade (Cat. No. IL4-H4218) is > 1.0ⅹ10^7 IU/mg, which is calibrated against human IL4 WHO International Stand (NIBSC code: 88/656) (Routinely tested).
Immobilized Human IL-4, His Tag (Cat. No. IL4-H52H9) at 5 μg/mL (100 μL/well) can bind Human IL-4 R alpha, Fc Tag (Cat. No. ILR-H5253) with a linear range of 0.5-16 ng/mL (QC tested).
The purity of Human IL-4, His Tag (Cat. No. IL4-H52H9) is more than 90% and the molecular weight of this protein is around 18-27 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Dectrekumab/VAK-694 | QBX-258 | Phase 2 Clinical | Novartis Pharma Ag | Lymphedema; Asthma | Details |
OCH-NCNP1 | OCH-NCNP1 | Phase 2 Clinical | Keio University | Multiple Sclerosis; Crohn Disease | Details |
AIR-645 | AIR-645; ISIS-369645 | Ionis Pharmaceuticals Inc | Details | ||
Romilkimab | SUB-33159; SAR-156597 | Sanofi | Details | ||
GSK-2434735 | GSK-2434735 | Glaxosmithkline Plc | Details | ||
VAK-694 | VAK-694; NVP-VAK-694 | Novartis Pharma Ag | Details | ||
Berdazimer sodium | NVN1000-SB206; MAP3-NONOate - SB-206; SB-019; NVN-1000-SB-206-Novan; SB-206 | Phase 3 Clinical | Novan Inc | Acne Vulgaris; Tinea Pedis; Psoriasis; Molluscum Contagiosum; Condylomata Acuminata; Dermatitis, Atopic | Details |
AUP1602-C | AUP-16; AUP1602-C | Phase 2 Clinical | Aurealis | Diabetic Foot | Details |
This web search service is supported by Google Inc.